WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02269 WUXI BIO

Not Yet Opened 07-20 16:08:22

38.260

+1.280

+3.46%

High38.860	Low37.140	Vol25.65M
Open37.740	D1 Closing36.980	Amplitude4.65%
Mkt Cap158.55B	Tradable Cap158.55B	Total Shares4.14B
T/O979.53M	T/O Rate0.62%	Tradable Shares4.14B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"WUXI BIO","latestPrice":38.26,"timestamp":1784534902001,"preClose":36.98,"halted":0,"volume":25652219,"delay":0,"changeRate":0.034613304488912956,"floatShares":4144000000,"shares":4144000000,"eps":1.3444369391323439,"marketStatus":"Not Yet Opened","change":1.28,"latestTime":"07-20 16:08:22","open":37.74,"high":38.86,"low":37.14,"amount":979531198,"amplitude":0.046512,"askPrice":38.26,"askSize":15500,"bidPrice":38.24,"bidSize":4500,"shortable":3,"etf":0,"ttmEps":1.3444369391323439,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784597400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":36.98,"openAndCloseTimeList":[[1784511000000,1784520000000],[1784523600000,1784534400000]],"volumeRatio":0.658795,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.5439,"impliedVolPercentile":0.6857},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2652296599","title":"Wuxi Biologics (cayman) Stock Advances 3.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2652296599","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652296599?lang=en_us&edition=fundamental","pubTime":"2026-07-20 16:31","pubTimestamp":1784536260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rallied 3.5% to 38.26 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 2.4% to 25143.05.The stock's rise snapped a two-day losing streak.Wuxi Biologics  Inc. closed 13% short of its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 25.7 million shares, compared to the 50-day average of 33.0 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 20, 2026 04:31 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU0359201612.USD","LU0417516738.SGD","BK1141","LU0051755006.USD","LU0043850808.USD","LU1794554557.SGD","LU1688375341.USD","LU0052750758.USD","LU0516422440.USD","LU0516422952.EUR","BK1610","LU1880383366.USD","LU0456827905.SGD","KURE","LU1242518931.SGD","LU0823426480.USD","LU0823426308.USD","LU0516423091.SGD","LU0327786744.USD","LU0516423174.USD","LU0588546209.SGD","SG9999002463.SGD","LU0348825331.USD","LU1720050803.USD","BK1589","LU0320764599.SGD","LU0359202008.SGD","LU0456846285.SGD","LU2039709279.SGD","SG9999002562.SGD","LU0516422366.SGD","02269","LU0181495838.USD","LU0417516902.SGD","BK1576","BK1521","LU0039217434.USD","LU0348735423.USD","LU0572944931.SGD","LU0708995583.HKD","LU0140636845.USD","LU0856984785.SGD","LU0979878070.USD","LU1242518857.USD","IE00B0JY6N72.USD","LU0307460666.USD","LU3063872942.SGD","LU0819121731.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185053835","title":"HK Movers | Biomedical Stocks Rally; REMEGEN, WUXI XDC and KEYMED BIO-B Surge Over 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185053835","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185053835?lang=en_us&edition=fundamental","pubTime":"2026-07-20 11:36","pubTimestamp":1784518575,"startTime":"0","endTime":"0","summary":"Monday, July 20, Hong Kong biomedical shares staged a broad rally. $REMEGEN(09995)$, $WUXI XDC(02268)$ and $KEYMED BIO-B(02162)$ climbed more than 8%, while $JUNSHI BIO(01877)$ gained over 7% and $AKESO(09926)$ advanced above 6%. $WUXI BIO(02269)$ edged up nearly 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","02162","01877","02269","02268","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128018085","title":"Movement Alert｜WuXi Biologics Rises 3.24% in Regular Trading, Star Fund Manager Zhao Feng Adds Stock as New Top-10 Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=1128018085","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128018085?lang=en_us&edition=fundamental","pubTime":"2026-07-20 09:56","pubTimestamp":1784512595,"startTime":"0","endTime":"0","summary":"On July 20, WuXi Biologics rose 3.24% in regular trading, trading at 38.66 HKD/share, with turnover of approximately 202 million HKD.On the news front, Ruiyuan Fund's prominent fund manager Zhao Feng...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652340510","title":"Wuxi Biologics (cayman) Stock Slips 6.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2652340510","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652340510?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:30","pubTimestamp":1784277000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 6.0% to 36.98 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.8% to 24562.24.This was the stock's second consecutive day of losses.Wuxi Biologics  Inc. closed 16% short of its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 51.3 million shares, compared to the 50-day average of 32.2 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 17, 2026 04:30 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","LU0052750758.USD","LU0039217434.USD","LU0181495838.USD","02269","BK1589","LU0417516902.SGD","LU0516423091.SGD","LU0326950275.SGD","LU0043850808.USD","LU0456846285.SGD","LU0856984785.SGD","LU3063872942.SGD","LU0359202008.SGD","BK1521","LU0819121731.USD","LU2039709279.SGD","LU0327786744.USD","LU0456827905.SGD","SG9999002463.SGD","LU0708995583.HKD","LU0516422440.USD","LU0823426480.USD","LU0348825331.USD","LU0307460666.USD","LU0417516738.SGD","LU0979878070.USD","LU0140636845.USD","SG9999002562.SGD","LU1688375341.USD","BK1610","IE00B0JY6N72.USD","LU0516422366.SGD","LU0516422952.EUR","LU1794554557.SGD","LU1242518857.USD","LU1242518931.SGD","LU1880383366.USD","LU0572944931.SGD","BK1141","LU0320764599.SGD","LU0348735423.USD","LU0359201612.USD","BK1576","LU0516423174.USD","LU0588546209.SGD","KURE","LU0823426308.USD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174497502","title":"Movement Alert｜WuXi Biologics Falls 3.26% in Regular Trading, Trading at 37.54 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1174497502","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174497502?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:14","pubTimestamp":1784254457,"startTime":"0","endTime":"0","summary":"On July 17, WuXi Biologics fell 3.26% in regular trading, trading at 37.54 HKD/share, with turnover of HKD 579 million.Within the Life Sciences Tools & Services sector where WuXi Biologics belongs,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652349478","title":"Wuxi XDC Files HKEX Next-day Disclosure Return, Share Capital Rises by 1,121,205 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2652349478","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652349478?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:31","pubTimestamp":1784244705,"startTime":"0","endTime":"0","summary":"WuXi XDC files HKEX next-day disclosure return, share capital rises by 1,121,205 sharesWuxi XDC filed a next-day disclosure return showing 1,121,205 new ordinary shares issued on July 16, 2026.Issuanc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL45qhGw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1688375341.USD","IE00B0JY6N72.USD","LU1880383366.USD","LU0359201612.USD","KURE","LU0823426480.USD","LU0348735423.USD","LU0359202008.SGD","LU0417516738.SGD","LU0516422366.SGD","LU0456827905.SGD","LU0516423091.SGD","LU0348825331.USD","BK1610","LU0326950275.SGD","LU0043850808.USD","BK1141","LU0417516902.SGD","LU0140636845.USD","LU0588546209.SGD","LU0456846285.SGD","LU0979878070.USD","LU0327786744.USD","LU1242518857.USD","LU3063872942.SGD","02269","LU0181495838.USD","02268","BK1576","LU0516423174.USD","SG9999002562.SGD","LU1720050803.USD","LU0039217434.USD","SG9999002463.SGD","LU0516422440.USD","LU0708995583.HKD","LU0307460666.USD","LU2039709279.SGD","LU0572944931.SGD","BK1521","LU0052750758.USD","LU0856984785.SGD","LU1794554557.SGD","LU0051755006.USD","LU0819121731.USD","LU0823426308.USD","LU0516422952.EUR","SG9999014674.SGD","LU0320764599.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107604247","title":"Research Monkey Prices Soar to A$20k, Supply Falls Short as CRO Industry Orders Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1107604247","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107604247?lang=en_us&edition=fundamental","pubTime":"2026-07-16 07:55","pubTimestamp":1784159708,"startTime":"0","endTime":"0","summary":"Recent activity in new drug development has made research monkeys a hot commodity again, with prices surging to as high as A$200,000 per animal.Data indicates that market demand for these primates...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","LU1880383366.USD","LU0052750758.USD","LU0039217434.USD","LU0359201612.USD","LU0140636845.USD","LU0572944931.SGD","LU0348766576.USD","LU0417516902.SGD","KURE","BK1576","LU0327786744.USD","LU0348767384.USD","VXUS","LU0516423174.USD","LU1688375341.USD","BK4588","LU0326950275.SGD","LU0456846285.SGD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0819121731.USD","LU1720050803.USD","BK1521","LU0823426480.USD","SG9999002463.SGD","02359","06127","LU0856984785.SGD","LU0320764599.SGD","BK4585","LU0181495838.USD","LU0359202008.SGD","BK1589","02269","BK1610","LU1242518931.SGD","LU0823426308.USD","LU1794554557.SGD","LU0516422366.SGD","LU0051755006.USD","LU0307460666.USD","LU1046422090.SGD","LU3063872942.SGD","LU0979878070.USD","LU2039709279.SGD","LU2125910500.SGD","03759","LU0043850808.USD","LU0588546209.SGD","LU2045819591.USD","LU0348735423.USD","BK1583","LU2242644610.SGD","LU1242518857.USD","BK1141","SG9999002562.SGD","KCAI","LU0516422952.EUR","LU0417516738.SGD","LU0516422440.USD","LU0456827905.SGD","LU0516423091.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651246453","title":"Wuxi Biologics (cayman) Stock Rallies 3.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2651246453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651246453?lang=en_us&edition=fundamental","pubTime":"2026-07-15 16:30","pubTimestamp":1784104200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 3.5% to 39.54 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.4% to 24681.10.This was the stock's second consecutive day of gains.Wuxi Biologics  Inc. closed 10% short of its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 54.8 million shares, compared to the 50-day average of 31.5 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 15, 2026 04:30 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU0417516738.SGD","LU0823426308.USD","LU0039217434.USD","LU0307460666.USD","LU0516423091.SGD","IE00B0JY6N72.USD","LU0359201612.USD","LU0856984785.SGD","LU0359202008.SGD","LU0051755006.USD","LU0348735423.USD","LU0572944931.SGD","LU1720050803.USD","LU0819121731.USD","BK1576","LU0516423174.USD","LU0708995583.HKD","LU0516422366.SGD","SG9999002463.SGD","BK1610","LU0320764599.SGD","LU1242518857.USD","LU1794554557.SGD","LU0456827905.SGD","LU0456846285.SGD","LU0326950275.SGD","BK1589","KURE","LU0043850808.USD","LU0516422952.EUR","SG9999002562.SGD","LU0327786744.USD","LU0823426480.USD","BK1521","LU0348825331.USD","LU0140636845.USD","LU1880383366.USD","LU0417516902.SGD","LU2039709279.SGD","LU0588546209.SGD","LU1242518931.SGD","LU1688375341.USD","02269","LU0979878070.USD","LU0516422440.USD","LU0181495838.USD","LU3063872942.SGD","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191068434","title":"Movement Alert｜WuXi Biologics Rises 3.66% in Regular Trading, Life Sciences Sector Rallies as FDA Approval Momentum Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=1191068434","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191068434?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:45","pubTimestamp":1784079926,"startTime":"0","endTime":"0","summary":"On July 15, WuXi Biologics rose 3.66% in regular trading, trading at HK$39.6/share with turnover of HK$254 million. The Life Sciences Tools & Services sector showed broad strength, with JOINN up...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651710156","title":"Wuxi XDC Files HKEX Next-day Disclosure Return, Share Capital Rises by 2,004,133 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2651710156","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651710156?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:56","pubTimestamp":1784037365,"startTime":"0","endTime":"0","summary":"WuXi XDC files HKEX next-day disclosure return, share capital rises by 2,004,133 sharesWuXi XDC filed a next-day disclosure return on July 14, 2026 covering share issuances from share option exercises.Issued 2,004,133 new ordinary shares from July 6-14, 2026 at exercise prices ranging from HKD 1.8 to HKD 7.5.Issued shares rose to 1,264,109,390 from 1,262,105,257; treasury shares remained at 0.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Cayman Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on July 14, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLx5d5k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU0856984785.SGD","LU0348735423.USD","LU1880383366.USD","LU0181495838.USD","SG9999014674.SGD","LU1242518931.SGD","LU0359202008.SGD","BK1589","LU0043850808.USD","LU2488822045.USD","LU0708995583.HKD","02269","LU0417516738.SGD","LU0417516902.SGD","02268","BK1521","LU0052750758.USD","LU0320764599.SGD","LU0823426308.USD","BK1576","LU0572944931.SGD","SG9999002463.SGD","LU1242518857.USD","LU0823426480.USD","KURE","LU1720050803.USD","LU0307460666.USD","LU1688375341.USD","BK1141","LU0516422440.USD","LU3063872942.SGD","SG9999002562.SGD","LU0348825331.USD","LU0456827905.SGD","IE00B0JY6N72.USD","LU0359201612.USD","LU2039709279.SGD","LU0819121731.USD","BK1610","LU0516423174.USD","LU0979878070.USD","LU0140636845.USD","LU0516422366.SGD","LU0039217434.USD","LU0327786744.USD","LU1794554557.SGD","LU0326950275.SGD","LU0588546209.SGD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183120568","title":"Movement Alert｜WuXi Biologics Declines 3.27% in Regular Trading, Trading at HK$37.0","url":"https://stock-news.laohu8.com/highlight/detail?id=1183120568","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183120568?lang=en_us&edition=fundamental","pubTime":"2026-07-14 10:04","pubTimestamp":1783994665,"startTime":"0","endTime":"0","summary":"On July 14, WuXi Biologics fell 3.27% in regular trading, trading at HK$37.0 per share, with turnover of HK$245 million.Within the Life Sciences Tools & Services sector where WuXi Biologics belongs,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651194444","title":"Wuxi Biologics (cayman) Stock Falls 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2651194444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651194444?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:32","pubTimestamp":1783931520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 1.7% to 37.32 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 24213.72.The stock's fall snapped a two-day winning streak.Wuxi Biologics  Inc. closed 15% below its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 25.0 million shares, compared to the 50-day average of 31.8 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 13, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU0572944931.SGD","LU2039709279.SGD","BK1610","IE00B0JY6N72.USD","LU0708995583.HKD","SG9999002562.SGD","LU0516422366.SGD","LU3063872942.SGD","LU0052750758.USD","LU0516423174.USD","LU0456846285.SGD","LU0307460666.USD","LU0979878070.USD","LU0823426308.USD","LU1720050803.USD","LU0359201612.USD","SG9999002463.SGD","LU0359202008.SGD","LU0348825331.USD","LU1688375341.USD","KURE","LU0051755006.USD","BK1521","BK1589","LU0326950275.SGD","LU0516423091.SGD","LU0417516902.SGD","02269","LU0181495838.USD","LU0043850808.USD","LU0856984785.SGD","BK1576","LU0327786744.USD","LU1242518857.USD","LU0348735423.USD","LU0140636845.USD","LU0417516738.SGD","LU0823426480.USD","LU1242518931.SGD","LU0516422952.EUR","LU0320764599.SGD","LU0039217434.USD","LU0819121731.USD","LU0456827905.SGD","LU1794554557.SGD","LU1880383366.USD","LU0516422440.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650526661","title":"WuXi Biologics (Cayman) (SEHK:2269) Wins FDA Inspection As Its Undervalued Case Builds","url":"https://stock-news.laohu8.com/highlight/detail?id=2650526661","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650526661?lang=en_us&edition=fundamental","pubTime":"2026-07-12 03:20","pubTimestamp":1783797611,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) (SEHK:2269) is back in focus after its MFG8 facility in Hebei cleared a seven day U.S. FDA Pre License Inspection, supporting commercial production of a potential autoimmune therapy.\nSee our latest analysis for WuXi Biologics (Cayman).\nAt a share price of HK$37.96, WuXi Biologics (Cayman) has seen a 26.79% 30 day share price return and a 16.66% year to date share price return. Its 1 year total shareholder return of 42.44% contrasts with weaker multi year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-wins-fda-inspection-as-its-un","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-wins-fda-inspection-as-its-un","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0516422366.SGD","LU0348735423.USD","BK1521","BK1576","LU0320764599.SGD","LU0819121731.USD","IE00B0JY6N72.USD","LU0516422440.USD","LU0327786744.USD","LU1880383366.USD","LU0588546209.SGD","BK1141","LU0456846285.SGD","LU0823426308.USD","LU0051755006.USD","SG9999002463.SGD","BK1610","LABU","BK4588","BK1589","LU0326950275.SGD","LU1242518931.SGD","LU0516423174.USD","LU0181495838.USD","LU0140636845.USD","LU1720050803.USD","LU0039217434.USD","LU0417516738.SGD","SG9999002562.SGD","LU0456827905.SGD","LU0348825331.USD","LU0307460666.USD","LU2039709279.SGD","LU0572944931.SGD","LU0359202008.SGD","LU0516423091.SGD","LU0856984785.SGD","LU0708995583.HKD","LU0823426480.USD","LU0979878070.USD","LU0052750758.USD","02269","LU1242518857.USD","LU0516422952.EUR","LU0359201612.USD","LU3063872942.SGD","LU0043850808.USD","BK4585","LU0417516902.SGD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185033","title":"TOT Biopharm Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650185033?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:10","pubTimestamp":1783674601,"startTime":"0","endTime":"0","summary":"TOT Biopharm schedules board meeting to review interim resultsTOT BioPharm will hold a board meeting on Aug. 21, 2026 to consider the group’s interim results for the six months ended June 30, 2026.Dis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDLttGpc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","LU0052750758.USD","LU0039217434.USD","01875","LU0181495838.USD","02269","BK1574","LU0417516902.SGD","LU0516423091.SGD","LU0326950275.SGD","LU0043850808.USD","LU0456846285.SGD","LU0856984785.SGD","LU0359202008.SGD","BK1521","LU0819121731.USD","LU2039709279.SGD","LU0327786744.USD","LU0456827905.SGD","SG9999002463.SGD","LU0708995583.HKD","LU0516422440.USD","LU0823426480.USD","LU0348825331.USD","LU0307460666.USD","LU0417516738.SGD","LU0979878070.USD","LU0140636845.USD","SG9999002562.SGD","LU1688375341.USD","BK1610","BK1161","IE00B0JY6N72.USD","LU0516422366.SGD","LU0516422952.EUR","LU1794554557.SGD","LU1242518857.USD","LU1242518931.SGD","LU1880383366.USD","LU0572944931.SGD","BK1141","LU0320764599.SGD","LU0348735423.USD","LU0359201612.USD","BK1576","LU0516423174.USD","LU0588546209.SGD","KURE","LU0823426308.USD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185441","title":"Wuxi XDC Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185441","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650185441?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:01","pubTimestamp":1783674114,"startTime":"0","endTime":"0","summary":"WuXi XDC schedules board meeting to review interim resultsWuxi XDC Cayman will hold a board meeting on Aug. 24, 2026 to review the group’s interim results for the six months ended June 30, 2026.Discla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL3NKKhZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","LU0320764599.SGD","LU0819121731.USD","SG9999002562.SGD","LU0326950275.SGD","LU0708995583.HKD","LU1242518857.USD","LU1794554557.SGD","LU0516422366.SGD","LU0572944931.SGD","LU3063872942.SGD","IE00B0JY6N72.USD","BK1141","LU0979878070.USD","LU1880383366.USD","SG9999002463.SGD","SG9999014674.SGD","LU0516423091.SGD","LU1720050803.USD","BK1576","BK1610","LU0140636845.USD","LU0856984785.SGD","BK1521","LU0516423174.USD","LU0417516902.SGD","LU1688375341.USD","LU0043850808.USD","LU0823426308.USD","LU0823426480.USD","LU0181495838.USD","LU0456846285.SGD","LU0327786744.USD","LU0348825331.USD","LU0359202008.SGD","02269","LU0348735423.USD","LU0516422952.EUR","LU0039217434.USD","LU0052750758.USD","BK1589","LU0417516738.SGD","LU0588546209.SGD","LU0307460666.USD","KURE","LU2488822045.USD","02268","LU0051755006.USD","LU2039709279.SGD","LU0516422440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650831441","title":"Wuxi Biologics (cayman) Stock Rises 2.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2650831441","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650831441?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:32","pubTimestamp":1783672320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rallied 2.4% to 37.96 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 24175.12.This was the stock's second consecutive day of gains.Wuxi Biologics  Inc. closed 14% short of its 52-week high of HK$44.00, which the company achieved Feb. 12.Trading volume totaled 46.3 million shares, compared to the 50-day average of 31.2 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 10, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0819121731.USD","LU0823426480.USD","LU0979878070.USD","LU0417516902.SGD","LU0456827905.SGD","BK1521","SG9999002463.SGD","LU0348825331.USD","BK1576","LU0326950275.SGD","LU0588546209.SGD","LU0348735423.USD","LU0359201612.USD","LU0181495838.USD","LU0039217434.USD","LU0051755006.USD","LU1242518857.USD","LU0140636845.USD","LU0856984785.SGD","BK1610","IE00B0JY6N72.USD","LU1794554557.SGD","LU0516423091.SGD","LU0327786744.USD","02269","BK1589","LU2039709279.SGD","LU0417516738.SGD","LU0516422366.SGD","LU1880383366.USD","LU0516422440.USD","SG9999002562.SGD","LU0516423174.USD","LU0823426308.USD","LU0043850808.USD","LU3063872942.SGD","LU0708995583.HKD","LU0052750758.USD","LU0307460666.USD","LU0516422952.EUR","LU0359202008.SGD","LU0572944931.SGD","LU1242518931.SGD","LU1688375341.USD","BK1141","LU0320764599.SGD","LU1720050803.USD","KURE","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185358101","title":"Movement Alert｜WuXi Biologics Rises 3.45% in Regular Trading, MFG8 Drug Substance Facility FDA Approval Continues to Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1185358101","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185358101?lang=en_us&edition=fundamental","pubTime":"2026-07-10 09:51","pubTimestamp":1783648285,"startTime":"0","endTime":"0","summary":"On July 10, WuXi Biologics rose 3.45% in regular trading, trading at HKD 38.28/share, with turnover of HKD 147 million.On the news front, the company's MFG8 drug substance manufacturing facility...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650394274","title":"Wuxi Biologics (cayman) Stock Rallies 3.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2650394274","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650394274?lang=en_us&edition=fundamental","pubTime":"2026-07-09 16:31","pubTimestamp":1783585860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. advanced 3.9% to 37.06 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.7% to 24030.18.The stock's rise snapped a two-day losing streak.Wuxi Biologics  Inc. closed 16% below its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 39.8 million shares, compared to the 50-day average of 30.8 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 09, 2026 04:31 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU1794554557.SGD","LU0456846285.SGD","BK1589","LU0348735423.USD","LU0516422366.SGD","LU0572944931.SGD","LU0043850808.USD","LU0819121731.USD","LU0823426308.USD","SG9999002562.SGD","LU0051755006.USD","BK1610","BK1141","LU0359201612.USD","LU0823426480.USD","LU0307460666.USD","LU0979878070.USD","LU2039709279.SGD","LU0052750758.USD","KURE","LU0516422440.USD","LU0708995583.HKD","LU0348825331.USD","LU0516422952.EUR","LU0359202008.SGD","BK1576","LU0417516738.SGD","IE00B0JY6N72.USD","LU0516423174.USD","LU3063872942.SGD","LU1720050803.USD","02269","LU0326950275.SGD","SG9999002463.SGD","LU0181495838.USD","LU0039217434.USD","LU0516423091.SGD","LU1688375341.USD","LU0856984785.SGD","LU0327786744.USD","LU0320764599.SGD","LU1880383366.USD","LU0588546209.SGD","LU0417516902.SGD","LU1242518857.USD","LU0456827905.SGD","LU0140636845.USD","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650387944","title":"Wuxi Biologics' MFG8 Drug Substance Facility Secures FDA Pli Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2650387944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650387944?lang=en_us&edition=fundamental","pubTime":"2026-07-09 15:31","pubTimestamp":1783582311,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nTUA6JQLZ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0307460666.USD","SG9999002463.SGD","LU1880383366.USD","LU0516422440.USD","LU0516422952.EUR","BK1141","BK1521","LU0348825331.USD","LU3063872942.SGD","BK1589","LU0708995583.HKD","LU0823426480.USD","LU1242518857.USD","LU0572944931.SGD","LU1794554557.SGD","LU0417516738.SGD","LU0588546209.SGD","LU0359202008.SGD","SG9999002562.SGD","LU2039709279.SGD","IE00B0JY6N72.USD","02269","LU0417516902.SGD","LU0327786744.USD","LU0456827905.SGD","KURE","LU0856984785.SGD","LU0348735423.USD","LU0039217434.USD","LU0516422366.SGD","LU1242518931.SGD","LU0181495838.USD","LU0516423091.SGD","LU1688375341.USD","LU1720050803.USD","LU0043850808.USD","BK1610","LU0823426308.USD","LU0819121731.USD","LU0516423174.USD","LU0051755006.USD","BK1576","LU0326950275.SGD","LU0052750758.USD","LU0456846285.SGD","LU0979878070.USD","LU0359201612.USD","LU0140636845.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113008372","title":"WUXI BIO Shares Surge Over 6% as MFG8 Facility Passes Key FDA Pre-Approval Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1113008372","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113008372?lang=en_us&edition=fundamental","pubTime":"2026-07-09 11:12","pubTimestamp":1783566724,"startTime":"0","endTime":"0","summary":"Shares of WUXI BIO (02269) surged more than 6% during the trading session. At the time of writing, the stock was up 4.99%, trading at HK$37.44 with a turnover of HK$660 million. The company announced...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0456827905.SGD","BK1141","IE00B0JY6N72.USD","LU1794554557.SGD","LU0348825331.USD","BK1589","LU0140636845.USD","LU0043850808.USD","BK1610","LU1720050803.USD","LU0516422366.SGD","BK1521","LU0320764599.SGD","LU0823426480.USD","IPOS","LABU","LU0327786744.USD","LU2039709279.SGD","LU0588546209.SGD","LU0307460666.USD","LU0039217434.USD","LU0051755006.USD","BK4585","02269","LU0979878070.USD","LU0516423091.SGD","LU0572944931.SGD","LU0516422952.EUR","LU0516423174.USD","LU0348735423.USD","LU0181495838.USD","LU0456846285.SGD","LU0823426308.USD","LU1242518931.SGD","SG9999002562.SGD","LU0856984785.SGD","LU0326950275.SGD","SG9999002463.SGD","LU1880383366.USD","LU0359201612.USD","LU0417516738.SGD","LU0708995583.HKD","LU0516422440.USD","LU1688375341.USD","KURE","LU1242518857.USD","LU0819121731.USD","LU3063872942.SGD","BK4588","LU0359202008.SGD","LU0417516902.SGD","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0252},{"period":"1month","weight":0.2414},{"period":"3month","weight":0.0839},{"period":"6month","weight":-0.0036},{"period":"1year","weight":0.3401},{"period":"ytd","weight":0.2169}],"compareEarnings":[{"period":"1week","weight":0.0384},{"period":"1month","weight":0.0509},{"period":"3month","weight":-0.0508},{"period":"6month","weight":-0.0542},{"period":"1year","weight":0.0128},{"period":"ytd","weight":-0.019}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052868},{"month":2,"riseRate":0.555556,"avgChangeRate":0.006907},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.001977},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000488},{"month":5,"riseRate":0.555556,"avgChangeRate":0.002485},{"month":6,"riseRate":0.666667,"avgChangeRate":0.061606},{"month":7,"riseRate":0.7,"avgChangeRate":0.0839},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030253},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056337},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.009161}],"exchange":"SEHK","name":"WUXI BIO","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WUXI BIO,02269,WUXI BIO股票,WUXI BIO股票老虎,WUXI BIO股票老虎国际,WUXI BIO行情,WUXI BIO股票行情,WUXI BIO股价,WUXI BIO股市,WUXI BIO股票价格,WUXI BIO股票交易,WUXI BIO股票购买,WUXI BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}